Sitemap
December 20, 2013 Articles
Filter by Available Specialty
- AAKP launches nutrition tracker
- AAP: Pregnant women, young children should avoid raw milk
- Ariad to resume Iclusig marketing with additional safety measures
- Baxter wins European approval for new home hemodialysis machine
- Close monitoring of methotrexate urged for pediatric IBD patients
- Experts outline measures to improve quality of PCI
- Healio Minute Friday, Dec. 20, 2013 Edition: Fracking chemicals called endocrine disrupters, breast cancer patients live longer, drug pairing with niacin lowers cholesterol
- Hearing often improved during bacterial meningitis recovery
- Heart disease remains No. 1 cause of death in US
- Immune response to cytomegalovirus affected RA patients’ reaction to DMARDs
- Increased daily ambulatory activity may reduce CV events
- InSite releases positive results for phase 3 trial of BromSite
- Many people with diabetes still lose vision, despite availability of vision-sparing treatment
- More fiber may lower risk for heart disease
- New delivery models for primary care optometry
- New mechanism identified in pathophysiology of PCOS
- New methods for real-time influenza forecasting appeared effective
- New methods for real-time influenza forecasting appeared effective
- Novel marker sensitive to diagnose fungal meningitis in outbreak
- Open adrenalectomy viable option in adrenocortical cancer
- Proliferative retinopathy in diabetes tied to cerebral microangiopathy
- Psychiatric morbidity risk higher in men with congenital adrenal hyperplasia
- Speaker recommends routine use of handheld navigation in TKR
- Study: Patients with diabetes may not receive care to prevent visual impairment, blindness
- TTE with contrast yielded lower mortality than non-contrast TTE in critically ill patients
- TTE with contrast yielded lower mortality than non-contrast TTE in critically ill patients
- Tumor staging finds most cSCC with positive SLNB occurred in T2 lesions
- Vaccine antibodies correlated with protection against HSV-1
- Variables may predict HCV patients likely to respond to peginterferon/ribavirin
- Variations between studies ‘not enough to question value of mammography’
- Vexim launches new bone fixation biomaterial